Permira, Sestant win EU approval for merger of blood-plasma businesses
MLex Summary: Buyout firm Permira and financial holding company Sestant have received EU approval to jointly acquire and combine blood-plasma drug rivals Kedrion and Bio Products Laboratory. The European Commission said...To view the full article, register now.
Already a subscriber? Click here to view full article